Jean Chretien's Pledge to Africa Act,
which allows generic drug firms to charge Third World
countries the cost of manufacturing plus an unprecedented,
low 15 per cent, has been stalled by technicalities,
according to government officials. In a Canadian Press
report, Tony Parmar of Doctors Without Borders,
»
more
|